You searched for "disease"
News from the International Vestibular Society
The executive committee of the International Vestibular Society has announced two new awards in vestibular science: one for basic and the second for clinical research. The society wishes to promote and encourage young researchers below 38, and allow the award...
Color Atlas of Oral Diseases: Diagnosis and Treatment – 4th edition
This is an excellent reference book in oral medicine which is clearly written by someone who has great experience, knowledge and passion in this field. The book is set out in a clear, concise and systematic manner where each condition...World Hearing Day 2023
The World Health Organization (WHO) is to launch a training guide on 3 March 2023 to mark this year’s World Hearing Day.Wilde and the foundations of medical epidemiology
William Wilde (father of Oscar) was renowned as an otologist, but less well known for his work in epidemiology. The bedrock of the modern discipline of public health is good data collection, and we hear from our good friend, Ray...The common frontal sinusotomy (Lothrop) and chronic rhinosinusitis
As our understanding of the pathophysiology of CRS evolves, so do our treatment strategies. It is accepted that in many cases, the main role of surgery is to allow better penetration of topical therapies to the sinus cavities. What, then,...When dinosaurs ruled the earth
Optimism is abundant in medical research, but frequently ends up being tempered with reality. In his inimitable style, Chris Potter looks back over his career – starting with his medical school memories of Bentley-driving ENT consultants, and moving forward through...
Can we predict how much benefit patients will get from ESS with a novel monoclonal antibody
Mepolizumab (Nucala) is a humanised IgG1 monoclonal antibody that acts as an IL-5 antagonist. It has been shown to be highly effective in treating severe asthma. It is hypothesised that it will be effective for patients with recalcitrant CRSwNP. This...
Neck dissection in adenoid cystic carcinoma is a risk worth taking?
This paper from Stanford University presents impressive figures to guide the debate on the extent of surgical management in adenoid cystic disease. Adenoid cystic carcinomas present a particular problem in that they can recur even after 20 years. They have...
MRI evaluation to assess the role of frusemide in reducing endolymphatic hydrops
Endolymphatic hydrops is generally considered to be a marker in Ménière’s disease and frusemide is used with the purpose of reducing it and improving symptoms. With the use of MRI, the authors have used the phenomenon of non-enhancing endolymphatic structures...
How should I excise sinonasal tumours, open or endoscopic? En bloc or piecemeal?
Sinonasal tumours often present late because initial symptoms mimic benign disease. They tend to produce more unilateral nasal symptoms, and patients with advance disease often describe paraesthesia and other cranial neuropathies. They only account for approximately 3% of upper aerodigestive...
